back to top
HomeTagsDisease

disease

New Medical Information Demonstrates Three Years of Steady Therapy with Twin-Appearing LEQEMBI (lecanemab-irmb) Continues to Considerably Profit Early Alzheimer's Illness Sufferers Offered at AAI...

TOKYO and CAMBRIDGE, Mass., Jul 31, 2024 - (JCN Newswire) - - Eisai Co (OTC:)., Ltd. and Biogen Inc (NASDAQ:). introduced at this time...

Merck acquires EyeBio to spice up retinal illness remedy By Investing.com

RAHWAY, N.J. - Merck & Co., Inc. (NYSE: MRK) has accomplished the acquisition of Eyebiotech Restricted (EyeBio), now a completely built-in subsidiary, enhancing its...

Most Popular

spot_img